Keyphrases
Multiple Myeloma
100%
Nanoparticles
36%
VLA-4
36%
Tumor
32%
P(LLA-CL)
32%
Molecular Imaging
31%
Myeloma Cells
30%
Optical Imaging
25%
Integrin
24%
Myeloma
21%
Radiopharmaceuticals
21%
Positron Emission Tomography
21%
Multiplexed Imaging
20%
Radionuclides
20%
CD38
18%
Daratumumab
18%
Non-invasive Imaging
18%
Bone Marrow
17%
Zirconium-89 (89Zr)
17%
Near-infrared
14%
Theranostics
13%
In Vivo Evaluation
13%
Nanophotosensitizer
11%
Bortezomib
11%
Bone Metastasis
11%
Preclinical Development
11%
Fluorescence Molecular Imaging
11%
Rhodium
11%
Imaging Applications
10%
Fluorescent Molecular Probes
10%
5TGM1
10%
Atrial Natriuretic Factor
10%
Molecular Targets
10%
Rutile
9%
Magnetic Resonance Imaging
9%
Targeted Nanoparticles
9%
Titanocene
9%
High Affinity
9%
Nanoprobe
8%
Structured Light
8%
18F-fluorodeoxyglucose (18F-FDG)
8%
Multiple Myeloma Patients
8%
Imaging Agents
8%
Tissue Biodistribution
8%
Near-infrared Fluorescent Dyes
8%
Radiotracer
8%
In Cellulo
7%
Dimethyl
7%
High Specificity
7%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
7%
Medicine and Dentistry
Multiple Myeloma
95%
Neoplasm
46%
Molecular Imaging
38%
Copper 64
32%
Positron Emission Tomography
25%
Treatment Response
22%
Myeloma
22%
Optical Imaging
22%
Diseases
21%
Polyethylene Terephthalate
21%
Metastatic Carcinoma
20%
Nanoparticle
18%
Myeloma Cell
18%
Bone Metastasis
17%
Zirconium 89
17%
Integrin
15%
Fluorodeoxyglucose F 18
13%
Immunotherapy
12%
Ex Vivo
12%
Daratumumab
11%
Bortezomib
11%
Imaging Agent
11%
Malignant Neoplasm
10%
In Vitro
9%
Radioactive Tracer
9%
Atrial Natriuretic Factor
9%
Comb
9%
Radiopharmaceutical
9%
Cardiovascular System
8%
Magnetic Resonance Imaging
8%
Macrophage
7%
Immunoglobulin Producing Cell
7%
Atherosclerosis
7%
Contrast Medium
7%
Bone Scintigraphy
7%
Positron Emission Tomography-Computed Tomography
7%
Imaging of Bone
6%
Dosimetry
6%
Drug Resistance
6%
Metastatic Breast Cancer
6%
Biodistribution
6%
Biological Marker
6%
Deferoxamine
6%
Flow Cytometry
6%
Very Late Activation Antigen 4
5%
Cell Therapy
5%
Transplantation
5%
Clinical Trial
5%
Chronic Intermittent Hypoxia
5%
Microsphere
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
52%
Neoplasm
32%
Nanoparticle
30%
Copper 64
26%
Malignant Neoplasm
21%
Radioisotope
20%
Polyethylene Terephthalate
18%
Zirconium 89
17%
Diseases
13%
Tracer
13%
Daratumumab
12%
Atrial Natriuretic Factor
9%
Integrin
9%
Iodine-125
8%
Metastasis
8%
Metastatic Breast Cancer
8%
Pharmacokinetics
8%
Chelating Agent
8%
Biodistribution
8%
Atherosclerosis
7%
Optical Imaging
6%
Deferoxamine
6%
Fluorodeoxyglucose F 18
6%
Immunotherapy
6%
Titanocene
6%
Dosimetry
5%
Peptidomimetics
5%
Microsphere
5%
Elotuzumab
5%
Somatostatin
5%
Prostate Cancer
5%
Bortezomib
5%
Photosensitizer
5%
Drug Resistance
5%
Liver Cell Carcinoma
5%
Yttrium 90
5%
Very Late Activation Antigen 4
5%
Integrin Receptor
5%
Bromine 76
5%
Double Stranded DNA
5%
Disseminated Cancer
5%
(3 Iodobenzyl)guanidine I 131
5%
Acetonitrile
5%
Clinical Trial
5%
Noradrenalin Transporter
5%
Macrogol
5%
Breast Cancer
5%
Transferrin
5%